<DOC>
	<DOCNO>NCT03098290</DOCNO>
	<brief_summary>The prevalence peripheral arterial disease ( PAD ) proportion endovascular procedure treatment increase worldwide . For many case treatment procedure randomize control trial ( RCT ) result meta-analyses far available . The decision treatment selection procedure therefore uncommonly leave personal expertise physician . The IDOMENEO study represent multistage multimethodological project healthcare research quality assurance interdisciplinary vascular medicine , undertakes comprehensive examination topic . Various method data source ( even routine data ) link meaningful way . The essential component total project implementation register platform ( GermanVasc ) , conforms data protection data security well development instrument valid measurement quality life patient PAD . The data protection-conform link primary data register routine data consortium partner BARMER also enable validation data source .</brief_summary>
	<brief_title>IDOMENEO - Is Treatment Reality Vascular Medicine Evidence-based Follows Guideline Recommendations ? A Project Quality Development Exemplified Peripheral Arterial Disease ( PAD )</brief_title>
	<detailed_description />
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<criteria>Symptomatic peripheral artery disease ( intermittent claudication critical limb ischemia ) Invasive treatment ( opensurgical endovascular ) Informed consent obtain No informed consent obtain</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>GermanVasc</keyword>
	<keyword>Peripheral Arterial Disease</keyword>
	<keyword>IDOMENEO</keyword>
	<keyword>Routine Data</keyword>
	<keyword>Registry Data</keyword>
	<keyword>Data Validity</keyword>
</DOC>